TSH stimulates the proliferation of vascular smooth muscle cells

Endocrine

Volumn 46, Issue 3, 2014, Pages 651-658

  Tian, Limin ^a   Ni, Jing ^b   Guo, Tiankang ^a   Liu, Jing ^a   Dang, Yamei ^a   Guo, Qian ^a   Zhang, Luyan ^a  

^a GANSU PROVINCIAL HOSPITAL   (China)

^b NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; Subclinical hypothyroidism; Thyroid stimulating hormone; Vascular smooth muscle cells

Indexed keywords

ALBUMIN; CYCLIC AMP; CYCLIN A; CYCLIN D; THYROTROPIN; THYROTROPIN RECEPTOR; CYCLIN D1;

ARTICLE; ATHEROSCLEROSIS; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PHASE; CELL CYCLE PROGRESSION; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GROWTH RATE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PHENOTYPE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SMOOTH MUSCLE FIBER; SUBCLINICAL HYPOTHYROIDISM; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; CYTOLOGY; DRUG EFFECTS; METABOLISM; SIGNAL TRANSDUCTION;

CELL PROLIFERATION; CYCLIC AMP; CYCLIN A; CYCLIN D1; HUMANS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; SIGNAL TRANSDUCTION; THYROTROPIN;

EID: 84904546574     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-013-0135-4     Document Type: Article

References (28)

1. G.J. Kahaly, W.H. Dillmann, Thyroid hormone action in the heart. Endocr. Rev. 26(5), 704-728 (2005)
2. T. Ichiki, Thyroid hormone and atherosclerosis. Vascul. Pharmacol. 52, 151-156 (2010)
3. I. Klein, S. Danzi, Thyroid disease and the heart. Circulation 116, 1725-1735 (2007)
4. G. Da Xiang, L.W. Xiang, H.L. He, L.S. Zhao, Post prandial lipaemia suppresses endothelium-dependent arterial dilation in patients with hypothyroidism. Endocrine 42, 391-398 (2012)
5. E. Cebeci, F.A. Oner, M. Usta, S. Yurdakul, M. Erguney, Evaluation of oxidative stress, the activities of paraoxonase and arylesterase in patients with subclinic hypothyroidism. Acta Biomed. 82, 214-222 (2011)
6. L.B. Yang, D.Q. Jiang, W.B. Qi, T. Zhang, Y.L. Feng, L. Gao, J. Zhao, Subclinical hyperthyroidism and the risk of cardiovascular events and all-cause mortality: an updated meta-analysis of cohort studies. Eur. J. Endocrinol. 167, 75-84 (2012)
7. G. Csaba, E. Pallinger, Thyrotropic hormone (TSH) regulation of triiodothyronine (T3) concentration in immune cells. Inflamm. Res. 58, 151-154 (2009)
8. M. Nannipieri, F. Cecchetti, M. Anselmino, S. Camastra, P. Niccolini, M. Lamacchia, M. Rossi, G. Iervasi, E. Ferrannini, Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and/or type 2 diabetes: effects of weight loss. Int. J. Obes. 33, 1001-1006 (2009)
9. K.A. Heemstra, W.M. van der Deure, R.P. Peeters, N.A. Hamdy, M.P. Stokkel, E.P. Corssmit, J.A. Romijn, T.J. Visser, J.W. Smit, Thyroid hormone independent associations between serum TSH levels and indicators of bone turnover in cured patients with differentiated thyroid carcinoma. Eur. J. Endocrinol. 159, 69-76 (2008)
10. W. Zhang, L.M. Tian, Y. Han, H.Y. Ma, L.C. Wang, J. Guo, L. Gao, J.J. Zhao, Presence of thyrotropin receptor in hepatocytes: not a case of illegitimate transcription. J. Cell. Mol. Med. 13, 4636-4642 (2009)
11. L. Tian, Y. Song, M. Xing, W. Zhang, G. Ning, X. Li, C. Yu, C. Qin, J. Liu, X. Tian, X. Sun, R. Fu, L. Zhang, X. Zhang, Y. Lu, J. Zou, L. Wang, Q. Guan, L. Gao, J.J. Zhao, A novel role for thyroid-stimulating hormone: up-regulation of hepatic 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase expression through the cyclic adenosine monophosphate/protein kinase A/cyclic adenosine monophosphate-responsive element binding protein pathway. Hepatology 52(4), 1401-1409 (2010)
12. D.F. Sellitti, D. Dennison, T. Akamizu, S.Q. Doi, L.D. Kohn, H. Koshiyama, Thyrotropin regulation of cyclic adenosinemonophosphate production in human coronary artery smooth muscle cells. Thyroid 10, 219-225 (2000)
13. A.R. Yoo, S.H. Koh, G.W. Cho, S.H. Kim, Inhibitory effects of cilostazol on proliferation of vascular smooth muscle cells (VSMCs) through suppression of the ERK1/2 pathway. J. Atheroscler. Thromb. 17, 1009-1018 (2010)
14. G.J. Song, N. Fiaschi-Taesch, A. Bisello, Endogenous parathyroid hormone-related protein regulates the expression of PTH type 1 receptor and proliferation of vascular smooth muscle cells. Mol. Endocrinol. (Baltimore, Md.) 23, 1681-1690 (2009)
15. K. Yokouchi, Y. Numaguchi, R. Kubota, M. Ishii, H. Imai, R. Murakami, Y. Ogawa, T. Kondo, K. Okumura, D.E. Ingber, T. Murohara, l-Caldesmon regulates proliferation and migration of vascular smooth muscle cells and inhibits neointimal formation after angioplasty. Arterioscler. Thromb. Vasc. Biol. 26(10), 2231-2237 (2006)
16. R. Zargham, Preventing restenosis after angioplasty: a multistage approach. Clin. Sci. (Lond). 114(4), 257-264 (2008)
17. Qifeng. Jiang, Renjian. Huang, Shaoxi. Cai, C.L. Wang, Caldesmon regulates the motility of vascular smooth muscle cells by modulating the actin cytoskeleton stability. J. Biomed. Sci. 17, 6 (2010)
18. D.N. Atochin, P.L. Huang, Endothelial nitric oxide synthase transgenic models of endothelial dysfunction. Pflugers Arch. 460(6), 965-974 (2010)
19. R. Napoli, V. Apuzzi, G. Bosso, C. D'Anna, A. De Sena, C. Pirozzi, A. Marano, G.A. Lupoli, G. Cudemo, U. Oliviero, Recombinant human thyrotropin enhances endothelial-mediated vasodilation of conduit arteries. J. Clin. Endocrinol. Metab. 94(3), 1012-1016 (2009)
20. R. Napoli, B. Biondi, V. Guardasole, C. D'Anna, A. De Sena, C. Pirozzi, D. Terracciano, C. Mazzarella, M. Matarazzo, L. Sacca, Enhancement of vascular endothelial function by recombinant human thyrotropin. J. Clin. Endocrinol. Metab. 93(5), 1959-1963 (2008)
21. A. Haribabu, V.S. Reddy, C. Pallavi, A.R. Bitla, A. Sachan, P. Pullaiah, V. Suresh, P.V. Rao, M.M. Suchitra, Evaluation of protein oxidation and its association with lipid peroxidation and thyrotropin levels in overt and subclinical hypothyroidism. Endocrine 44, 152-157 (2013)
22. P. Agretti, G. De Marco, M. De Servi, C. Marcocci, P. Vitti, A. Pinchera, M. Tonacchera, Evidence for protein and mRNA TSHr expression in fibroblasts from patients with thyroid-associated ophthalmopathy (TAO) after adipocytic differentiation. Eur. J. Endocrinol. 152, 777-784 (2005)
23. T.T. Antunes, A. Gagnon, A. Bell, A. Sorisky, Thyroid-stimulating hormone stimulates interleukin-6 release from 3T3-L1 adipocytes through a cAMP-protein kinase A pathway. Obes. Res. 13, 2066-2071 (2005)
24. H. Guo, N. Makarova, Y. Cheng, E. Shuyu, R.R. Ji, C. Zhang, P. Farrarc, G. Tigyia, The early- and late stages in phenotypic modulation of vascular smooth muscle cells: differential roles for lysophosphatidic acid. Biochim. Biophys. Acta 1781(9), 571-581 (2008)
25. E.M. Rzucidlo, Signaling pathways regulating vascular smooth muscle cell differentiation. Vascular 17(Suppl 1), S15-S20 (2009)
26. R.E. Clempus, D. Sorescu, A.E. Dikalova, L. Pounkova, P. Jo, G.P. Sorescu, B. Lassègue, K.K. Griendling, Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype. Arterioscler. Thromb. Vasc. Biol. 27(1), 42-48 (2007)
27. C.L. Wang, Caldesmon and the regulation of cytoskeletal functions. Adv. Exp. Med. Biol. 644, 250-272 (2008)
28. E.S. Park, J.M. Yoo, Y. Lim, M. Tudev, H.S. Yoo, J.T. Hong, Y.P. Yun, Inhibitory effects of docetaxel on platelet-derived growth factor (PDGF)-BB-induced proliferation of vascular smooth muscle cells through blocking PDGF-receptor beta phosphorylation. J. Pharmacol. Sci. 116(2), 204-213 (2011)